SITABASE 100
Description
- Contains Sitagliptin Phosphate Monohydrate 100 mg, a DPP-4 inhibitor.
- Helps regulate blood glucose by enhancing incretin hormone activity.
- Effective in managing type 2 diabetes alongside diet and exercise.
- Low risk of hypoglycemia when used as monotherapy.
- Convenient once-daily oral tablet.
- Can be used alone or in combination with other antidiabetic agents.
- Supports improved pancreatic beta-cell function and insulin secretion.
Composition
SITAGLIPTIN PHOSPHATE MONOHYDRATE-100 MG
Benefits
SITABASE 100 offers significant benefits in managing type 2 diabetes by effectively lowering fasting and postprandial blood glucose levels without causing significant hypoglycemia. It improves pancreatic beta-cell function and promotes balanced blood sugar levels throughout the day. With once-daily oral dosing, SITABASE 100 supports improved patient compliance and helps reduce the risk of diabetes-related complications, making it an important part of comprehensive diabetes care.
Introduction
SITABASE 100 contains Sitagliptin Phosphate Monohydrate 100 mg, a highly effective oral antidiabetic medication used to improve blood sugar control in patients with type 2 diabetes mellitus. Sitagliptin belongs to the class of DPP-4 inhibitors, which work by increasing the levels of incretin hormones that regulate insulin secretion and glucagon release. This helps to enhance glucose-dependent insulin secretion and reduce elevated blood sugar levels, supporting better glycemic control alongside diet and exercise.
